ArticleTherapeutic advances in medical oncology2020

MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III study.

Qing Yuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.